Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study

Lamarche, Benoiˆt; Moorjani, Sital; Lupien, Paul J.; Cantin, Bernard; Bernard, Paul-Marie; Dagenais, Gilles R.; Despre´s, Jean-Pierre

doi:10.1161/01.cir.94.3.273

Cited by 476Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disorders

Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study

Lamarche, Benoiˆt, Moorjani, Sital, Lupien, Paul J., Cantin, Bernard, Bernard, Paul-Marie, Dagenais, Gilles R., Despre´s, Jean-Pierre·1996·Circulation

DOI 10.1161/01.cir.94.3.273

Open this paper in CoChat — free account

Abstract

Background Results obtained largely from case-control studies have suggested that an elevated plasma concentration of apolipoprotein (apo) B may be considered an important risk factor for ischemic heart disease (IHD). Prospective data on the relevance of measuring apo A-I and apo B levels in the assessment of IHD risk, however, remain sparse as well as controversial. Methods and Results Plasma lipid, apo B, and apo A-I levels as well as other risk factors were evaluated at baseline in 1985 in a sample of 2155 men (45 to 76 years old) who were followed for a period of 5 years for clinical signs of IHD. Proportional-hazards analyses indicated that plasma apo B concentrations measured at entry were strongly associated with onset of IHD (relative rate, 1.4; 95% confidence interval [CI], 1.2 to 1.7), independent of covariables such as age, smoking, diabetes mellitus, and systolic blood pressure. Controlling for triglycerides, HDL cholesterol, and total/HDL cholesterol ratio did not eliminate the relationship between plasma apo B levels and IHD. The association between apo A-I and IHD was of lower magnitude (relative rate, 0.85; 95% CI, 0.7 to 1.0), and adjustment for selected plasma lipid and lipoprotein levels eliminated this association. Stepwise logistic regression analysis revealed that, among metabolic variables, apo B was the strongest correlate of IHD. Conclusions These prospective results emphasize the importance of apo B as a risk factor for IHD. Apo B may be regarded as a relevant tool in the assessment of IHD risk in men, because it may provide information that would not be obtained from the conventional lipid-lipoprotein profile.

Integrity signals

Registry

Crossref · 10.1161/01.cir.94.3.273

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Increased apoB concentrations can reflect an increased cardiovascular risk.
“increased apoB concentrations can reflect an increased cardiovascular risk [43].”
From Effects of aerobic exercise on lipids and lipoproteins (2017) · cites this paper as [43]

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
Laurell, C. (1966) · Analytical Biochemistry · doi:10.1016/0003-2697(66)90246-6 · Cited by 4,428 · see citing works
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,305 · see citing works
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159 · see citing works
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,620 · see citing works
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547 · see citing works
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411 · see citing works
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
Manninen, V, Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.37 · Cited by 1,329 · see citing works
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163 · see citing works
Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)
Assmann, G., & Schulte, H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90550-i · Cited by 872 · see citing works
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].
Sniderman, A. D., Shapiro, S., Marpole, D. G. F., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 632 · see citing works
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537 · see citing works
Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT
Kannel, W. B., Neaton, J. D., Wentworth, D. N., Thomas, H. E., Stamler, J., Hulley, S. B., & Kjelsberg, M. O. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90481-3 · Cited by 502 · see citing works
International diagnostic criteria for acute myocardial infarction and acute stroke
Gillum, R. F., Fortmann, S. P., Prineas, R. J., & Kottke, T. E. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90558-1 · Cited by 486 · see citing works
Recent progress in understanding apolipoprotein B.
Young, S. G. (1990) · Circulation · doi:10.1161/01.cir.82.5.1574 · Cited by 421 · see citing works
Alcohol and Coronary Heart Disease
Marmot, M. G. (1984) · International Journal of Epidemiology · doi:10.1093/ije/13.2.160 · Cited by 360 · see citing works
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material
Marcovina, S. M., Albers, J. J., Henderson, L. O., & Hannon, W. H. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.5.773 · Cited by 342 · see citing works
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Ordovás, J. M., Jenner, J. L., Silberman, S. R., Anderson, K. M., Wilson, P. W. F., Salem, D. N., & Schaefer, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90520-w · Cited by 333 · see citing works
High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
Gordon, D. J., Knoke, J. D., Probstfield, J. L., Superko, H. R., & Tyroler, H. A. (1986) · Circulation · doi:10.1161/01.cir.74.6.1217 · Cited by 289 · see citing works
APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASE
Durrington, P. N., Hunt, L. P., Ishola, M., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91895-8 · Cited by 284 · see citing works
Apoproteins B and A-I and coronary artery disease in humans.
Brunzell, J. D., Sniderman, A. D., Albers, J. J., & Kwiterovich, P. O. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.2.79 · Cited by 279 · see citing works
Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease
Salonen, J. T., Salonen, R. M., Penttilä, I., Herranen, J., Jauhiainen, M., Kantola, M., Lappeteläinen, R., Mäenpää, P. H., Alfthan, G., & Puska, P. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90839-2 · Cited by 264 · see citing works
International federation of clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of international reference material
Marcovina, S. M., Albers, J. J., Kennedy, H., Mei, J. V., Henderson, L. O., & Hannon, W. H. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.4.586 · Cited by 243 · see citing works
Apolipoproteins and ischaemic heart disease: implications for screening
Wald, N., Watt, H., Bailey, A., Johnson, M., Ledue, T. B., & Haddow, J. E. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90814-1 · Cited by 241 · see citing works
Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery Disease
Rader, D. J., Hoeg, J. M., & Brewer, H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-12-199406150-00008 · Cited by 225 · see citing works
Lipid Research Clinics Program Reference Values for Hyperlipidemia and Hypolipidemia
Rifkind, B. M. (1983) · JAMA · doi:10.1001/jama.1983.03340140039025 · Cited by 215 · see citing works
Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma
Moorjani, S., Dupont, A., Labrie, F., Lupien, P.-J., Brun, D., Gagné, C., Giguère, M., & Bélanger, A. (1987) · Metabolism · doi:10.1016/0026-0495(87)90183-1 · Cited by 204 · see citing works
Self-citation
Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein.
Albers, J. J., Warnick, G. R., Wiebe, D. A., King, P. J., Steiner, P. M., Smith, L., Breckenridge, C., Chow, A., Kuba, K., Weidman, S. W., et al. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.6.853 · Cited by 196 · see citing works
Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men
Sigurðsson, G., Baldursdóttir, Á., Sigvaldason, H., Agnarsson, U., Þorgeirsson, G., & Sigfússon, N. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91215-p · Cited by 187 · see citing works
Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease
Kwiterovich, P. O., Coresh, J., Smith, H. H., Bachorik, P. S., Derby, C. A., & Pearson, T. A. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90856-t · Cited by 178 · see citing works
Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Que´bec cardiovascular study)
Lamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80760-7 · Cited by 170 · see citing works
Self-citation
Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: A cooperative lipoprotein phenotyping study
Castelli, W. P., Cooper, G. R., Doyle, J. T., García-Palmieri, M. R., Gordon, T., Hames, C. G., Hulley, S. B., Kagan, A., Kuchmak, M., McGee, D., et al. (1977) · Journal of Chronic Diseases · doi:10.1016/0021-9681(77)90082-0 · Cited by 147 · see citing works
Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.
Kesäniemi, Y. A., Beltz, W. F., & Grundy, S. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112010 · Cited by 140 · see citing works
The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease
ISHIKAWA, T., Fidge, N., Thelle, D. S., Førde, O. H., & Miller, N. E. (1978) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1978.tb00832.x · Cited by 126 · see citing works
Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease
GENESTJR, J., Bard, J., Fruchart, J., Ordovás, J. M., WILSON, P., & Schaefer, E. J. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90109-g · Cited by 122 · see citing works
PLASMACYTOMA OF PANCREAS AND DUODENUM CAUSING ACUTE INTESTINAL OBSTRUCTION
Hefferman, A. (1947) · The Lancet · doi:10.1016/s0140-6736(47)91368-8 · Cited by 90 · see citing works
Plasma apoproteins and the severity of coronary artery disease.
Sedlis, S. P., Schechtman, K. B., Ludbrook, P. A., Sobel, B. E., & Schonfeld, G. (1986) · Circulation · doi:10.1161/01.cir.73.5.978 · Cited by 76 · see citing works
The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery Disease
O’Brien, T., Nguyen, T. T., Hallaway, B. J., Hodge, D. O., Bailey, K. R., Holmes, D. R., & Kottke, B. A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.228 · Cited by 69 · see citing works
Does measurement of apolipoprotein B have a place in cholesterol management?
Vega, G. L., & Grundy, S. M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.5.668 · Cited by 64 · see citing works
Overproduction of low density lipoproteins associated with coronary heart disease.
Kesäniemi, Y. A., & Grundy, S. M. (1983) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.3.1.40 · Cited by 62 · see citing works
The ratio of plasma high-density lipoprotein cholesterol to total and low-density lipoprotein cholesterol: age-related changes and race and sex differences in selected North American populations. The Lipid Research Clinics Program Prevalence Study.
Green, M. S., HEISS, G. M., Rifkind, B. M., Cooper, G. R., Williams, O. D., & Tyroler, H. A. (1985) · Circulation · doi:10.1161/01.cir.72.1.93 · Cited by 58 · see citing works
First coronary heart disease event rates in relation to major risk factors: Quebec cardiovascular study.
Dagenais, G. R., Robitaille, N. M., Lupien, P. J., Christen, A., Gingras, S., Moorjani, S., Meyer, F., & Rochon, J. (1990) · PubMed · Cited by 49 · see citing works
Self-citation
Atherosclerosis and apoproteins B and A-I
Kwiterovich, P. O., & Sniderman, A. D. (1983) · Preventive Medicine · doi:10.1016/0091-7435(83)90265-7 · Cited by 44 · see citing works
Cardiovascular risk factor clustering and ratio of total cholesterol to high-density lipoprotein cholesterol in angiographically documented coronary artery disease
Luria, M. H., Erel, J., Sapoznikov, D., & Gotsman, M. S. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90094-2 · Cited by 43 · see citing works
Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (The Que´bec Cardiovascular Study)
Cantin, B., Moorjani, S., Dagenais, G. R., & Lupien, P.-J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80767-x · Cited by 29 · see citing works
Self-citation
Clinical Value of Apolipoprotein Measurement
Bhatnagar, D., & Durrington, P. N. (1991) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329102800501 · Cited by 22 · see citing works
The measurement of apolipoprotein B should replace the conventional lipid profile in screening for cardiovascular risk.
Sniderman, A. D. (1992) · PubMed · Cited by 16 · see citing works

Flagged first, then by citations

Sorted by citations

Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814 · see citing works
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men: Prospective Results From the Que´bec Cardiovascular Study
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077 · see citing works
Self-citation
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case–control study
McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., Steyn, K., Sanderson, J. E., Hasani, M., Volkova, E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61076-4 · Cited by 864 · see citing works
Non–HDL Cholesterol, Apolipoproteins A-I and B <sub>100</sub> , Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women
Ridker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.3.326 · Cited by 744 · see citing works
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
Ingelsson, E., Schaefer, E. J., Contois, J. H., McNamara, J. R., Sullivan, L., Keyes, M. J., Pencina, M. J., Schoonmaker, C., Wilson, P. W. F., D’Agostino, R. B., et al. (2007) · JAMA · doi:10.1001/jama.298.7.776 · Cited by 608 · see citing works
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
Pischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514 · see citing works
Atherogenic Lipoprotein Particles in Atherosclerosis
Carmena, R., Duriez, P., & Fruchart, J.-C. (2004) · Circulation · doi:10.1161/01.cir.0000131511.50734.44 · Cited by 494 · see citing works
Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.
Carr, M. C., & Brunzell, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0432 · Cited by 493 · see citing works
Effects of aerobic exercise on lipids and lipoproteins
Wang, Y., & Xu, D. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0515-5 · Cited by 436 · see citing works
Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
Contois, J. H., McConnell, J. P., Sethi, A. A., Csako, G., Devaraj, S., Hoefner, D. M., & Warnick, G. R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118356 · Cited by 326 · see citing works
The Insulin Resistance—Dyslipidemic Syndrome of Visceral Obesity: Effect on Patients' Risk
Després, J. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00683.x · Cited by 261 · see citing works
Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies
THOMPSON, A., & DANESH, J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01644.x · Cited by 252 · see citing works
Role of <i>Spirulina</i> in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus
Parikh, P., Mani, U., & Iyer, U. (2001) · Journal of Medicinal Food · doi:10.1089/10966200152744463 · Cited by 193 · see citing works
Blood lipid response to 20 weeks of supervised exercise in a large biracial population: The HERITAGE family study
Leon, A. S., Rice, T., Mandel, S., Despres, J.-P., Bergeron, J., Gagnon, J., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80018-9 · Cited by 176 · see citing works
Self-citation
High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men.
Davy, B. M., Davy, K. P., Ho, R. C., Beske, S. D., Davrath, L. R., & Melby, C. L. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.351 · Cited by 161 · see citing works
Non–High-Density Lipoprotein Cholesterol Versus Apolipoprotein B in Cardiovascular Risk Stratification
Ramjee, V., Sperling, L. S., & Jacobson, T. A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.009 · Cited by 157 · see citing works
Approach to lipoprotein management in 2001 National Cholesterol Guidelines
Grundy, S. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02631-0 · Cited by 128 · see citing works
Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review
Benn, M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.004 · Cited by 119 · see citing works
Apolipoproteins as markers and managers of coronary risk
Chan, D. C. (2006) · QJM · doi:10.1093/qjmed/hcl027 · Cited by 117 · see citing works
Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
Chien, K.-L., Hsu, H.-C., Su, T.-C., Chen, M.-F., Lee, Y.-T., & Hu, F. B. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700213-jlr200 · Cited by 109 · see citing works
A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.
de Graaf, J., Couture, P., & Sniderman, A. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0982 · Cited by 80 · see citing works
The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
Blackburn, P., Lemieux, I., Alméras, N., Bergeron, J., Côté, M., Tremblay, A., Lamarche, B., & Després, J.-P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.03.012 · Cited by 67 · see citing works
Self-citation
Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review
Sandhu, P. K., Musaad, S. M. A., Remaley, A. T., Buehler, S. S., Strider, S., Derzon, J. H., Vesper, H. W., Ranne, A., Shaw, C. S., & Christenson, R. H. (2016) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.021006 · Cited by 55 · see citing works
Do age and baseline LDL cholesterol levels determine the effect of regular exercise on plasma lipoprotein cholesterol and apolipoprotein B levels?
Angelopoulos, T. J., Sivo, S. A., Kyriazis, G. A., Caplan, J. D., Zoeller, R. F., Lowndes, J., Seip, R. L., & Thompson, P. D. (2007) · European Journal of Applied Physiology · doi:10.1007/s00421-007-0537-1 · Cited by 6 · see citing works

Authors: Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P.
Affiliations: the Lipid Research Center, Laval University Hospital Research Center, Ste-Foy (B.L., S.M., P.J.L., B.C., J.-P.D.); the Department of Social and Preventive Medicine, Laval University, Que´bec (P.-M.B.); and the Department of Medicine, University of Montre´al (G.R.D.), Que´bec, Canada.
Université Laval (CA)
ORCID: Dagenais, Gilles R.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1996-08
Volume: 94
Issue: 3
Pages: 273-278
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.94.3.273
OpenAlex: W1988933958
Cited by: 476
References: 47
Citations by year: 2026: 2 · 2025: 4 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 12 · 2015: 10 · 2014: 18 · 2013: 14 · 2012: 25
FWCI: 15.02
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: apolipoprotein A-I, apolipoprotein B, ischemic heart disease, cardiovascular risk factors, plasma lipids, men, HDL cholesterol, triglycerides, TC/HDL-C ratio, lipoproteins
MeSH terms: Aged, Apolipoproteins B, Follow-Up Studies, Forecasting, Humans, Cholesterol, HDL, Male, Middle Aged, Prospective Studies, Risk Factors, Cohort Studies, Proportional Hazards Models, Survival Analysis, Apolipoprotein A-I, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks